World's Best Scientists 2026 revealed!
Yoshihiro Oka

Yoshihiro Oka

D-Index & Metrics

Immunology

D-Index
58
Citations
11715
World Ranking
3528
National Ranking
140

Yoshihiro Oka publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yoshihiro Oka sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 211 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yoshihiro Oka D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshihiro Oka sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yoshihiro Oka is affiliated with Osaka University in Japan and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans diverse subfields including Molecular Biology, Immunology, Reproductive Medicine, Oncology, and Social Psychology.

The scientist's research extensively explores topics such as hypothalamic control of reproductive hormones, renal and related cancers, immunotherapy and immune responses, CAR-T cell therapy research, cancer immunotherapy and biomarkers, neuroendocrine regulation and behavior, and reproductive biology and its impacts on aquatic species.

Frequent coauthors collaborating with Yoshihiro Oka include Haruo Sugiyama, Yusuke Oji, Akihiro Tsuboi, Hiroko Nakajima, and Jun Nakata. Together, their work has been published in several scientific venues, with multiple articles appearing in Cancer Immunology Immunotherapy, bioRxiv (Cold Spring Harbor Laboratory), Current Medicinal Chemistry, ZOOLOGICAL SCIENCE, and Journal of Neuroendocrinology.

Selected recent papers authored by or involving Yoshihiro Oka include:

  • TMC4 is a novel chloride channel involved in high-concentration salt taste sensation (2021, The Journal of Physiological Sciences)
  • Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain (2022, Science Translational Medicine)
  • Multiple gonadotropin-releasing hormone systems in non-mammalian vertebrates: Ontogeny, anatomy, and physiology (2021, Journal of Neuroendocrinology)
  • Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer (2021, Journal of Immunotherapy)
  • Estrogen upregulates the firing activity of hypothalamic gonadotropin-releasing hormone (GnRH1) neurons in the evening in female medaka (2022, Journal of Neuroendocrinology)

Best Publications

  • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

    Yoshihiro Oka;Akihiro Tsuboi;Tetsuya Taguchi;Tadashi Osaki

  • Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

    Kazushi Inoue;Hiroyasu Ogawa;Hiroyasu Ogawa;Yoshiaki Sonoda;Yoshiaki Sonoda;Takafumi Kimura;Takafumi Kimura

  • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

    Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

  • Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.

    Yoshihiro Oka;Olga A. Elisseeva;Akihiro Tsuboi;Hiroyasu Ogawa

  • Immunohistochemical detection of WT1 protein in a variety of cancer cells

    Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

  • Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product

    Yoshihiro Oka;Keiko Udaka;Akihiro Tsuboi;Olga A. Elisseeva

  • The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.

    Hiroyasu Ogawa;Hiroya Tamaki;Kazuhiro Ikegame;Toshihiro Soma

  • Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

    Yusuke Oji;Shinichiro Miyoshi;Hajime Maeda;Seiji Hayashi

  • Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

    Kazushi Inoue;Hiroya Tamaki;Hiroyasu Ogawa;Yoshihiro Oka

  • Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

    Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

  • Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies.

    Olga A. Elisseeva;Yoshihiro Oka;Akihiro Tsuboi;Kiyoyuki Ogata

  • Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.

    Yusuke Oji;Shoji Nakamori;Masahiro Fujikawa;Shin-ichi Nakatsuka

  • Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

    Naoki Hosen;Yoshiaki Sonoda;Yusuke Oji;Takafumi Kimura

  • Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors

    Yusuke Oji;Tsuyoshi Suzuki;Yoko Nakano;Motohiko Maruno

  • The activated conformation of integrin β 7 is a novel multiple myeloma–specific target for CAR T cell therapy

    Naoki Hosen;Yukiko Matsunaga;Kana Hasegawa;Hiroshi Matsuno

  • Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

    Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

  • Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma

    Yusuke Oji;Hirofumi Yamamoto;Masaya Nomura;Yoko Nakano

  • AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

    Sumiyuki Nishida;Naoki Hosen;Toshiaki Shirakata;Keisuke Kanato

  • Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

    Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

  • WT1 peptide vaccine for the treatment of cancer.

    Yoshihiro Oka;Akihiro Tsuboi;Yusuke Oji;Ichiro Kawase

  • Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

    Akihiro Tsuboi;Yoshihiro Oka;Hiroyasu Ogawa;Olga A Elisseeva

Frequent Co-Authors

Haruo Sugiyama
Haruo Sugiyama Osaka University
Yusuke Oji
Yusuke Oji Osaka University
Atsushi Kumanogoh
Atsushi Kumanogoh Osaka University
Katsuyuki Aozasa
Katsuyuki Aozasa Osaka University
Satoshi Morita
Satoshi Morita Kyoto University
Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Masaki Yasukawa
Masaki Yasukawa Ehime University
Eiichi Morii
Eiichi Morii Osaka University
Shinzaburo Noguchi
Shinzaburo Noguchi Osaka University
Toshihisa Komori
Toshihisa Komori Nagasaki University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. For individuals interested in advancing their clinical skills, accelerated NP programs offer a fast track to becoming a Nurse Practitioner. This pathway is especially valuable for those looking to transition quickly into high-demand roles.

Nurses aiming to specialize further can consider acute care certification for FNP, which equips Family Nurse Practitioners with the skills needed to manage complex patient cases in acute settings. This additional credential expands career options significantly.

For those starting from scratch, the best online BSN programs for non nurses provide an accessible route to enter the nursing field without prior healthcare experience. These programs are designed to build foundational knowledge effectively through online learning formats.

Salary transparency is vital when planning your career path. Understanding DNP salary transparency across states helps prospective students make informed decisions about where to study and work after graduation, optimizing both educational investment and future earnings.

To explore these opportunities further, visit accelerated NP program, acute care certification for FNP, best online BSN programs for non nurses, and DNP salary transparency.

Best Scientists Citing Yoshihiro Oka

Trending Scientists

Recently Published Articles